Skip to main content
Caplight Logo









Cirqle Biomedical

Cirqle Biomedical

Private
CopenhagenHealthcare & Life Scienceshttps://www.cirqle.bio/

Last Round

Corporate Funding

Jul 28, 2022

Total Funding Raised

$11.8M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Cirqle Biomedical is a biotechnology company developing a non-hormonal, on-demand contraceptive that reinforces the natural cervical mucus barrier to prevent pregnancy.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

non-hormonal contraceptionfemtechmucus engineeringcontraceptive gelbirth controlbiotechbiomaterialsdrug discoveryreproductive healthpharmaceutical licensingwomen's health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cirqle Biomedical Comparables

Compare Cirqle Biomedical with similar companies based on industry and business-model similarity.

Cirqle Biomedical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Elle, MD Biotechnologies
78%
Daré Bioscience Inc
76%
Evofem Biosciences, Inc.
76%

Cirqle Biomedical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingJul 28, 2022
VC RoundJun 2, 2022
Pre SeedAug 27, 2019

Key People

Founding team and executive leadership

Frederik Petursson Madsen

CEO

Executive Team

Cirqle Biomedical Investors

Notable investors and investment history

Cirqle Biomedical investors
InvestorRounds
BioInnovation InstituteVC Round, Pre Seed
RH CapitalVC Round
Rhia VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 12, 2026

    Monthly visitors increased 723% MoM.

  • Jun 2, 2022

    Raised capital from RH Capital and BioInnovation Institute.

Cirqle Biomedical Filings

Explore SEC and related filing metadata, where available.

Cirqle Biomedical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cirqle Biomedical's valuation, stock price, and market status.

Is Cirqle Biomedical a public or private company?

Cirqle Biomedical is a private company.

What is the current stock price of Cirqle Biomedical?

Cirqle Biomedical is a private company with no public stock price. No recent secondary market data is available.

How much is Cirqle Biomedical worth (valuation)?

Valuation information for Cirqle Biomedical is not publicly available.

Can I buy Cirqle Biomedical stock?

Cirqle Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cirqle Biomedical's last funding round?

Cirqle Biomedical's most recent funding round was Strategic on July 28, 2022.

Who are the main investors in Cirqle Biomedical?

Key investors in Cirqle Biomedical include BioInnovation Institute, Rhia Ventures.

Will Cirqle Biomedical IPO soon?

No public IPO plans have been announced for Cirqle Biomedical.

How can I track Cirqle Biomedical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cirqle Biomedical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCopenhagen
Employee Range4
Year Founded2018
Last FundingJul 28, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?